Home > Healthcare > Biotechnology > Bioservices > Spatial Genomics and Transcriptomics Market

Spatial Genomics and Transcriptomics Market Trends

Report ID: GMI5968
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Spatial Genomics and Transcriptomics Market Trends

The market is experiencing several key trends that are shaping its development and driving innovation. Some of the prominent trends in the field include integration of spatial and single-cell technologies, advancements in imaging technologies, emergence of in-situ sequencing techniques, and increasing adoption of machine learning and computational analysis. These key trends are driving advancements and innovation in the market, leading to the development of more powerful and sophisticated tools and applications.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for spatial genomics and transcriptomics was worth over USD 305.5 million in 2022 and is projected to record over 15% CAGR through 2032, owing to increasing research focus on spatial biology, growing demand for deeper insights into cellular function & organization, and advances in sequencing technologies.

The translational research segment will grow at more than 18% CAGR between 2023 to 2032, as the application aims to bridge the gap between basic research discoveries and their practicality in clinical settings. Translation research highlights the potential clinical relevance and utility of spatial genomics and transcriptomics technologies.

North America spatial genomics and transcriptomics market will register a growth rate of over 15% during 2023-2032, on account of a robust R&D landscape in the region, along with a high concentration of pharmaceutical & biotechnology companies, academic institutions, and research organizations.

Natera Inc., 10x Genomics, Dovetail Genomics, Illumina, Inc., S2 Genomics, Inc., NanoString Technologies, Inc., Seven Bridges Genomics, Horizon Discovery Group plc, CARTANA AB, READCOOR, INC., Bio-Techne Corporation, and Bio-Rad Laboratories, Inc. among others.